PDB Short entry for 2FNA HEADER ATP-BINDING PROTEIN 10-JAN-06 2FNA TITLE CRYSTAL STRUCTURE OF AN ARCHAEAL AAA+ ATPASE (SSO1545) FROM SULFOLOBUS TITLE 2 SOLFATARICUS P2 AT 2.00 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: CONSERVED HYPOTHETICAL PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SULFOLOBUS SOLFATARICUS; SOURCE 3 ORGANISM_TAXID: 273057; SOURCE 4 STRAIN: P2; SOURCE 5 GENE: 13814777; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-2, ATP-BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 25-JAN-23 2FNA 1 REMARK SEQADV LINK REVDAT 5 13-JUL-11 2FNA 1 VERSN REVDAT 4 23-MAR-11 2FNA 1 HEADER TITLE KEYWDS REVDAT 3 10-MAR-09 2FNA 1 JRNL REVDAT 2 24-FEB-09 2FNA 1 VERSN REVDAT 1 07-FEB-06 2FNA 0 JRNL AUTH Q.XU,C.L.RIFE,D.CARLTON,M.D.MILLER,S.S.KRISHNA,M.A.ELSLIGER, JRNL AUTH 2 P.ABDUBEK,T.ASTAKHOVA,H.J.CHIU,T.CLAYTON,L.DUAN,J.FEUERHELM, JRNL AUTH 3 S.K.GRZECHNIK,J.HALE,G.W.HAN,L.JAROSZEWSKI,K.K.JIN, JRNL AUTH 4 H.E.KLOCK,M.W.KNUTH,A.KUMAR,D.MCMULLAN,A.T.MORSE, JRNL AUTH 5 E.NIGOGHOSSIAN,L.OKACH,S.OOMMACHEN,J.PAULSEN,R.REYES, JRNL AUTH 6 H.VAN DEN BEDEM,K.O.HODGSON,J.WOOLEY,A.M.DEACON,A.GODZIK, JRNL AUTH 7 S.A.LESLEY,I.A.WILSON JRNL TITL CRYSTAL STRUCTURE OF A NOVEL ARCHAEAL AAA+ ATPASE SSO1545 JRNL TITL 2 FROM SULFOLOBUS SOLFATARICUS. JRNL REF PROTEINS V. 74 1041 2009 JRNL REFN ISSN 0887-3585 JRNL PMID 19089981 JRNL DOI 10.1002/PROT.22325 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 69.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 51161 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2733 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3667 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.2360 REMARK 3 BIN FREE R VALUE SET COUNT : 203 REMARK 3 BIN FREE R VALUE : 0.2950 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5688 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 347 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.30000 REMARK 3 B22 (A**2) : 1.17000 REMARK 3 B33 (A**2) : 0.88000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.71000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.172 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.161 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.124 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.233 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5942 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 5552 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8020 ; 1.425 ; 2.000 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12865 ; 0.818 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 720 ; 5.772 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 277 ;33.827 ;23.791 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1092 ;14.787 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 43 ;17.074 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 884 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6483 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1256 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1193 ; 0.214 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5483 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2880 ; 0.185 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 3445 ; 0.082 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 321 ; 0.163 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 1 ; 0.018 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 7 ; 0.119 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 53 ; 0.218 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.120 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3629 ; 1.961 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1440 ; 0.485 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5686 ; 2.923 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2634 ; 4.934 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2324 ; 6.568 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 356 REMARK 3 ORIGIN FOR THE GROUP (A): -0.5051 50.2761 49.4028 REMARK 3 T TENSOR REMARK 3 T11: -0.0904 T22: -0.0747 REMARK 3 T33: -0.1257 T12: -0.0613 REMARK 3 T13: 0.0265 T23: -0.0038 REMARK 3 L TENSOR REMARK 3 L11: 2.4925 L22: 1.1371 REMARK 3 L33: 0.9742 L12: -0.4942 REMARK 3 L13: 0.3927 L23: -0.1682 REMARK 3 S TENSOR REMARK 3 S11: -0.0174 S12: 0.0343 S13: -0.0924 REMARK 3 S21: 0.0755 S22: -0.0562 S23: 0.1694 REMARK 3 S31: -0.0246 S32: 0.0524 S33: 0.0736 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 356 REMARK 3 ORIGIN FOR THE GROUP (A): 18.4135 48.8463 84.7034 REMARK 3 T TENSOR REMARK 3 T11: -0.0923 T22: -0.0962 REMARK 3 T33: -0.1300 T12: 0.0434 REMARK 3 T13: 0.0037 T23: -0.0193 REMARK 3 L TENSOR REMARK 3 L11: 1.8422 L22: 1.4717 REMARK 3 L33: 0.7058 L12: -0.2608 REMARK 3 L13: 0.2192 L23: -0.1128 REMARK 3 S TENSOR REMARK 3 S11: 0.1129 S12: 0.2331 S13: 0.0451 REMARK 3 S21: -0.1593 S22: -0.0545 S23: 0.1436 REMARK 3 S31: -0.0314 S32: 0.0556 S33: -0.0584 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE REMARK 3 SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 TO ACCOUNT FOR REMARK 3 THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. REMARK 3 3. ADP AND MG WERE MODELED BASED ON ELECTRON DENSITY AND THE REMARK 3 PROTEIN'S PROPOSED FUNCTION AS AN ATPASE. REMARK 3 4. RESIDUES 115-119 ARE DISORDERED IN EACH CHAIN AND WERE NOT REMARK 3 MODELED. REMARK 4 REMARK 4 2FNA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000036079. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95372, 0.979996 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL, SI(111) REMARK 200 OPTICS : ADJUSTABLE FOCUSING MIRRORS IN K REMARK 200 -B GEOMETRY REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53921 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 69.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.6 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.5300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.42400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.0% PEG-8000, 0.1M CHES, PH 9.5, REMARK 280 VAPOR DIFFUSION,SITTING DROP,NANODROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 54.17500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TRP A 115 REMARK 465 ASN A 116 REMARK 465 ARG A 117 REMARK 465 LYS A 118 REMARK 465 ASP A 119 REMARK 465 TRP B 115 REMARK 465 ASN B 116 REMARK 465 ARG B 117 REMARK 465 LYS B 118 REMARK 465 ASP B 119 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 19 CD CE NZ REMARK 470 GLU A 22 CD OE1 OE2 REMARK 470 ARG A 63 CZ NH1 NH2 REMARK 470 LYS A 74 CD CE NZ REMARK 470 LEU A 78 CG CD1 CD2 REMARK 470 LYS A 82 CE NZ REMARK 470 LYS A 99 CE NZ REMARK 470 ASN A 100 CG OD1 ND2 REMARK 470 MSE A 107 CG SE CE REMARK 470 LYS A 112 CD CE NZ REMARK 470 ASN A 114 CG OD1 ND2 REMARK 470 LYS A 135 CG CD CE NZ REMARK 470 LYS A 229 CD CE NZ REMARK 470 LYS A 271 CE NZ REMARK 470 LYS A 289 CE NZ REMARK 470 LYS A 300 CD CE NZ REMARK 470 ILE A 317 CG1 CG2 CD1 REMARK 470 GLU A 318 CG CD OE1 OE2 REMARK 470 LYS A 339 CE NZ REMARK 470 GLU A 340 CG CD OE1 OE2 REMARK 470 LYS A 343 CD CE NZ REMARK 470 LYS B 12 CG CD CE NZ REMARK 470 LYS B 19 CD CE NZ REMARK 470 ARG B 28 NE CZ NH1 NH2 REMARK 470 LYS B 82 CE NZ REMARK 470 LYS B 89 CE NZ REMARK 470 LYS B 96 CG CD CE NZ REMARK 470 LYS B 99 CG CD CE NZ REMARK 470 ASN B 100 CG OD1 ND2 REMARK 470 GLN B 102 CG CD OE1 NE2 REMARK 470 LYS B 112 CG CD CE NZ REMARK 470 ASN B 114 CG OD1 ND2 REMARK 470 LYS B 135 CG CD CE NZ REMARK 470 LYS B 168 CE NZ REMARK 470 GLU B 189 CD OE1 OE2 REMARK 470 LYS B 303 CE NZ REMARK 470 GLU B 318 CD OE1 OE2 REMARK 470 GLU B 340 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 284 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 284 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 16 -124.35 41.32 REMARK 500 LEU A 91 77.50 -115.39 REMARK 500 MSE A 107 104.53 -171.41 REMARK 500 GLU A 144 53.53 73.20 REMARK 500 ASP A 230 45.68 -86.98 REMARK 500 CYS A 301 161.33 69.66 REMARK 500 GLU A 340 -70.58 -89.50 REMARK 500 ASP B 16 -130.65 52.36 REMARK 500 ARG B 17 23.98 47.02 REMARK 500 ASN B 100 57.30 -110.75 REMARK 500 GLU B 144 53.75 71.95 REMARK 500 ASP B 230 47.76 -94.97 REMARK 500 CYS B 301 166.64 64.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 400 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 43 OG REMARK 620 2 ADP A 500 O3B 95.3 REMARK 620 3 HOH A 637 O 84.2 97.6 REMARK 620 4 HOH A 668 O 173.5 91.2 94.4 REMARK 620 5 HOH A 669 O 82.5 175.7 85.9 91.0 REMARK 620 6 HOH A 670 O 86.3 88.0 169.3 94.5 88.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 400 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 43 OG REMARK 620 2 ADP B 500 O3B 90.5 REMARK 620 3 HOH B 666 O 87.0 85.2 REMARK 620 4 HOH B 667 O 89.9 171.2 86.1 REMARK 620 5 HOH B 683 O 176.4 93.0 94.3 86.8 REMARK 620 6 HOH B 684 O 88.8 97.2 175.1 91.5 89.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 359645 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE REMARK 999 TARGET SEQUENCE. DBREF 2FNA A 1 356 GB 13814777 AAK41763 1 356 DBREF 2FNA B 1 356 GB 13814777 AAK41763 1 356 SEQADV 2FNA GLY A 0 GB 13814777 EXPRESSION TAG SEQADV 2FNA MSE A 1 GB 13814777 MET 1 MODIFIED RESIDUE SEQADV 2FNA MSE A 107 GB 13814777 MET 107 MODIFIED RESIDUE SEQADV 2FNA MSE A 174 GB 13814777 MET 174 MODIFIED RESIDUE SEQADV 2FNA MSE A 179 GB 13814777 MET 179 MODIFIED RESIDUE SEQADV 2FNA MSE A 295 GB 13814777 MET 295 MODIFIED RESIDUE SEQADV 2FNA GLY B 0 GB 13814777 EXPRESSION TAG SEQADV 2FNA MSE B 1 GB 13814777 MET 1 MODIFIED RESIDUE SEQADV 2FNA MSE B 107 GB 13814777 MET 107 MODIFIED RESIDUE SEQADV 2FNA MSE B 174 GB 13814777 MET 174 MODIFIED RESIDUE SEQADV 2FNA MSE B 179 GB 13814777 MET 179 MODIFIED RESIDUE SEQADV 2FNA MSE B 295 GB 13814777 MET 295 MODIFIED RESIDUE SEQRES 1 A 357 GLY MSE LEU PHE ASP THR SER PRO LYS ASP ASN ARG LYS SEQRES 2 A 357 ASP PHE PHE ASP ARG GLU LYS GLU ILE GLU LYS LEU LYS SEQRES 3 A 357 GLY LEU ARG ALA PRO ILE THR LEU VAL LEU GLY LEU ARG SEQRES 4 A 357 ARG THR GLY LYS SER SER ILE ILE LYS ILE GLY ILE ASN SEQRES 5 A 357 GLU LEU ASN LEU PRO TYR ILE TYR LEU ASP LEU ARG LYS SEQRES 6 A 357 PHE GLU GLU ARG ASN TYR ILE SER TYR LYS ASP PHE LEU SEQRES 7 A 357 LEU GLU LEU GLN LYS GLU ILE ASN LYS LEU VAL LYS ARG SEQRES 8 A 357 LEU PRO SER LEU LEU LYS ALA LEU LYS ASN ILE GLN GLY SEQRES 9 A 357 ILE VAL ILE MSE GLY ASN GLU ILE LYS PHE ASN TRP ASN SEQRES 10 A 357 ARG LYS ASP ARG LEU SER PHE ALA ASN LEU LEU GLU SER SEQRES 11 A 357 PHE GLU GLN ALA SER LYS ASP ASN VAL ILE ILE VAL LEU SEQRES 12 A 357 ASP GLU ALA GLN GLU LEU VAL LYS LEU ARG GLY VAL ASN SEQRES 13 A 357 LEU LEU PRO ALA LEU ALA TYR ALA TYR ASP ASN LEU LYS SEQRES 14 A 357 ARG ILE LYS PHE ILE MSE SER GLY SER GLU MSE GLY LEU SEQRES 15 A 357 LEU TYR ASP TYR LEU ARG VAL GLU ASP PRO GLU SER PRO SEQRES 16 A 357 LEU PHE GLY ARG ALA PHE SER THR VAL GLU LEU LYS PRO SEQRES 17 A 357 PHE SER ARG GLU GLU ALA ILE GLU PHE LEU ARG ARG GLY SEQRES 18 A 357 PHE GLN GLU ALA ASP ILE ASP PHE LYS ASP TYR GLU VAL SEQRES 19 A 357 VAL TYR GLU LYS ILE GLY GLY ILE PRO GLY TRP LEU THR SEQRES 20 A 357 TYR PHE GLY PHE ILE TYR LEU ASP ASN LYS ASN LEU ASP SEQRES 21 A 357 PHE ALA ILE ASN GLN THR LEU GLU TYR ALA LYS LYS LEU SEQRES 22 A 357 ILE LEU LYS GLU PHE GLU ASN PHE LEU HIS GLY ARG GLU SEQRES 23 A 357 ILE ALA ARG LYS ARG TYR LEU ASN ILE MSE ARG THR LEU SEQRES 24 A 357 SER LYS CYS GLY LYS TRP SER ASP VAL LYS ARG ALA LEU SEQRES 25 A 357 GLU LEU GLU GLU GLY ILE GLU ILE SER ASP SER GLU ILE SEQRES 26 A 357 TYR ASN TYR LEU THR GLN LEU THR LYS HIS SER TRP ILE SEQRES 27 A 357 ILE LYS GLU GLY GLU LYS TYR CYS PRO SER GLU PRO LEU SEQRES 28 A 357 ILE SER LEU ALA PHE SER SEQRES 1 B 357 GLY MSE LEU PHE ASP THR SER PRO LYS ASP ASN ARG LYS SEQRES 2 B 357 ASP PHE PHE ASP ARG GLU LYS GLU ILE GLU LYS LEU LYS SEQRES 3 B 357 GLY LEU ARG ALA PRO ILE THR LEU VAL LEU GLY LEU ARG SEQRES 4 B 357 ARG THR GLY LYS SER SER ILE ILE LYS ILE GLY ILE ASN SEQRES 5 B 357 GLU LEU ASN LEU PRO TYR ILE TYR LEU ASP LEU ARG LYS SEQRES 6 B 357 PHE GLU GLU ARG ASN TYR ILE SER TYR LYS ASP PHE LEU SEQRES 7 B 357 LEU GLU LEU GLN LYS GLU ILE ASN LYS LEU VAL LYS ARG SEQRES 8 B 357 LEU PRO SER LEU LEU LYS ALA LEU LYS ASN ILE GLN GLY SEQRES 9 B 357 ILE VAL ILE MSE GLY ASN GLU ILE LYS PHE ASN TRP ASN SEQRES 10 B 357 ARG LYS ASP ARG LEU SER PHE ALA ASN LEU LEU GLU SER SEQRES 11 B 357 PHE GLU GLN ALA SER LYS ASP ASN VAL ILE ILE VAL LEU SEQRES 12 B 357 ASP GLU ALA GLN GLU LEU VAL LYS LEU ARG GLY VAL ASN SEQRES 13 B 357 LEU LEU PRO ALA LEU ALA TYR ALA TYR ASP ASN LEU LYS SEQRES 14 B 357 ARG ILE LYS PHE ILE MSE SER GLY SER GLU MSE GLY LEU SEQRES 15 B 357 LEU TYR ASP TYR LEU ARG VAL GLU ASP PRO GLU SER PRO SEQRES 16 B 357 LEU PHE GLY ARG ALA PHE SER THR VAL GLU LEU LYS PRO SEQRES 17 B 357 PHE SER ARG GLU GLU ALA ILE GLU PHE LEU ARG ARG GLY SEQRES 18 B 357 PHE GLN GLU ALA ASP ILE ASP PHE LYS ASP TYR GLU VAL SEQRES 19 B 357 VAL TYR GLU LYS ILE GLY GLY ILE PRO GLY TRP LEU THR SEQRES 20 B 357 TYR PHE GLY PHE ILE TYR LEU ASP ASN LYS ASN LEU ASP SEQRES 21 B 357 PHE ALA ILE ASN GLN THR LEU GLU TYR ALA LYS LYS LEU SEQRES 22 B 357 ILE LEU LYS GLU PHE GLU ASN PHE LEU HIS GLY ARG GLU SEQRES 23 B 357 ILE ALA ARG LYS ARG TYR LEU ASN ILE MSE ARG THR LEU SEQRES 24 B 357 SER LYS CYS GLY LYS TRP SER ASP VAL LYS ARG ALA LEU SEQRES 25 B 357 GLU LEU GLU GLU GLY ILE GLU ILE SER ASP SER GLU ILE SEQRES 26 B 357 TYR ASN TYR LEU THR GLN LEU THR LYS HIS SER TRP ILE SEQRES 27 B 357 ILE LYS GLU GLY GLU LYS TYR CYS PRO SER GLU PRO LEU SEQRES 28 B 357 ILE SER LEU ALA PHE SER MODRES 2FNA MSE A 1 MET SELENOMETHIONINE MODRES 2FNA MSE A 107 MET SELENOMETHIONINE MODRES 2FNA MSE A 174 MET SELENOMETHIONINE MODRES 2FNA MSE A 179 MET SELENOMETHIONINE MODRES 2FNA MSE A 295 MET SELENOMETHIONINE MODRES 2FNA MSE B 1 MET SELENOMETHIONINE MODRES 2FNA MSE B 107 MET SELENOMETHIONINE MODRES 2FNA MSE B 174 MET SELENOMETHIONINE MODRES 2FNA MSE B 179 MET SELENOMETHIONINE MODRES 2FNA MSE B 295 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 107 5 HET MSE A 174 8 HET MSE A 179 8 HET MSE A 295 8 HET MSE B 1 8 HET MSE B 107 8 HET MSE B 174 8 HET MSE B 179 13 HET MSE B 295 8 HET MG A 400 1 HET ADP A 500 27 HET EDO A 501 4 HET EDO A 502 4 HET EDO A 503 4 HET EDO A 504 4 HET EDO A 505 4 HET EDO A 506 4 HET MG B 400 1 HET ADP B 500 27 HET EDO B 501 4 HETNAM MSE SELENOMETHIONINE HETNAM MG MAGNESIUM ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 10(C5 H11 N O2 SE) FORMUL 3 MG 2(MG 2+) FORMUL 4 ADP 2(C10 H15 N5 O10 P2) FORMUL 5 EDO 7(C2 H6 O2) FORMUL 14 HOH *347(H2 O) HELIX 1 1 ASN A 10 PHE A 14 5 5 HELIX 2 2 ARG A 17 LEU A 27 1 11 HELIX 3 3 GLY A 41 ASN A 54 1 14 HELIX 4 4 ARG A 63 GLU A 66 5 4 HELIX 5 5 SER A 72 LEU A 91 1 20 HELIX 6 6 SER A 93 LEU A 98 1 6 HELIX 7 7 SER A 122 ALA A 133 1 12 HELIX 8 8 ALA A 145 LEU A 151 5 7 HELIX 9 9 LEU A 156 LEU A 167 1 12 HELIX 10 10 GLU A 178 LEU A 186 1 9 HELIX 11 11 SER A 209 ASP A 225 1 17 HELIX 12 12 ASP A 230 GLY A 239 1 10 HELIX 13 13 ILE A 241 LYS A 256 1 16 HELIX 14 14 ASN A 257 HIS A 282 1 26 HELIX 15 15 ARG A 284 ILE A 286 5 3 HELIX 16 16 ALA A 287 SER A 299 1 13 HELIX 17 17 LYS A 303 GLY A 316 1 14 HELIX 18 18 SER A 320 HIS A 334 1 15 HELIX 19 19 GLU A 348 PHE A 355 1 8 HELIX 20 20 ASN B 10 PHE B 14 5 5 HELIX 21 21 ARG B 17 LEU B 27 1 11 HELIX 22 22 GLY B 41 ASN B 54 1 14 HELIX 23 23 ARG B 63 GLU B 66 5 4 HELIX 24 24 SER B 72 LEU B 91 1 20 HELIX 25 25 SER B 93 ASN B 100 1 8 HELIX 26 26 SER B 122 ALA B 133 1 12 HELIX 27 27 GLU B 144 LEU B 151 5 8 HELIX 28 28 LEU B 156 LEU B 167 1 12 HELIX 29 29 GLU B 178 LEU B 186 1 9 HELIX 30 30 SER B 209 ASP B 225 1 17 HELIX 31 31 ASP B 230 GLY B 239 1 10 HELIX 32 32 ILE B 241 LYS B 256 1 16 HELIX 33 33 ASN B 257 HIS B 282 1 26 HELIX 34 34 ARG B 284 ILE B 286 5 3 HELIX 35 35 ALA B 287 LEU B 298 1 12 HELIX 36 36 SER B 299 CYS B 301 5 3 HELIX 37 37 LYS B 303 GLY B 316 1 14 HELIX 38 38 SER B 320 HIS B 334 1 15 HELIX 39 39 GLU B 348 PHE B 355 1 8 SHEET 1 A 5 TYR A 57 ASP A 61 0 SHEET 2 A 5 VAL A 138 ASP A 143 1 O VAL A 141 N LEU A 60 SHEET 3 A 5 ILE A 170 GLY A 176 1 O ILE A 173 N ILE A 140 SHEET 4 A 5 ILE A 31 GLY A 36 1 N THR A 32 O MSE A 174 SHEET 5 A 5 SER A 201 LEU A 205 1 O VAL A 203 N LEU A 35 SHEET 1 B 2 ILE A 104 ILE A 106 0 SHEET 2 B 2 ILE A 111 PHE A 113 -1 O LYS A 112 N VAL A 105 SHEET 1 C 2 ILE A 337 LYS A 339 0 SHEET 2 C 2 TYR A 344 PRO A 346 -1 O CYS A 345 N ILE A 338 SHEET 1 D 5 TYR B 57 ASP B 61 0 SHEET 2 D 5 VAL B 138 ASP B 143 1 O VAL B 141 N ILE B 58 SHEET 3 D 5 ILE B 170 GLY B 176 1 O LYS B 171 N ILE B 140 SHEET 4 D 5 ILE B 31 LEU B 35 1 N THR B 32 O MSE B 174 SHEET 5 D 5 SER B 201 GLU B 204 1 O SER B 201 N LEU B 33 SHEET 1 E 2 VAL B 105 MSE B 107 0 SHEET 2 E 2 GLU B 110 LYS B 112 -1 O GLU B 110 N MSE B 107 SHEET 1 F 2 ILE B 337 GLU B 340 0 SHEET 2 F 2 LYS B 343 PRO B 346 -1 O LYS B 343 N GLU B 340 SSBOND 1 CYS B 301 CYS B 345 1555 1555 2.61 LINK C GLY A 0 N MSE A 1 1555 1555 1.32 LINK C MSE A 1 N LEU A 2 1555 1555 1.32 LINK C ILE A 106 N MSE A 107 1555 1555 1.33 LINK C MSE A 107 N GLY A 108 1555 1555 1.34 LINK C ILE A 173 N MSE A 174 1555 1555 1.33 LINK C MSE A 174 N SER A 175 1555 1555 1.32 LINK C GLU A 178 N MSE A 179 1555 1555 1.32 LINK C MSE A 179 N GLY A 180 1555 1555 1.32 LINK C ILE A 294 N MSE A 295 1555 1555 1.34 LINK C MSE A 295 N ARG A 296 1555 1555 1.32 LINK C GLY B 0 N MSE B 1 1555 1555 1.34 LINK C MSE B 1 N LEU B 2 1555 1555 1.32 LINK C ILE B 106 N MSE B 107 1555 1555 1.33 LINK C MSE B 107 N GLY B 108 1555 1555 1.33 LINK C ILE B 173 N MSE B 174 1555 1555 1.32 LINK C MSE B 174 N SER B 175 1555 1555 1.32 LINK C GLU B 178 N MSE B 179 1555 1555 1.33 LINK C MSE B 179 N GLY B 180 1555 1555 1.33 LINK C ILE B 294 N MSE B 295 1555 1555 1.31 LINK C MSE B 295 N ARG B 296 1555 1555 1.33 LINK OG SER A 43 MG MG A 400 1555 1555 2.15 LINK MG MG A 400 O3B ADP A 500 1555 1555 2.01 LINK MG MG A 400 O HOH A 637 1555 1555 1.99 LINK MG MG A 400 O HOH A 668 1555 1555 2.12 LINK MG MG A 400 O HOH A 669 1555 1555 2.13 LINK MG MG A 400 O HOH A 670 1555 1555 2.11 LINK OG SER B 43 MG MG B 400 1555 1555 2.07 LINK MG MG B 400 O3B ADP B 500 1555 1555 2.08 LINK MG MG B 400 O HOH B 666 1555 1555 2.09 LINK MG MG B 400 O HOH B 667 1555 1555 2.15 LINK MG MG B 400 O HOH B 683 1555 1555 2.13 LINK MG MG B 400 O HOH B 684 1555 1555 2.03 CISPEP 1 MSE A 107 GLY A 108 0 -9.02 SITE 1 AC1 6 SER A 43 ADP A 500 HOH A 637 HOH A 668 SITE 2 AC1 6 HOH A 669 HOH A 670 SITE 1 AC2 6 SER B 43 ADP B 500 HOH B 666 HOH B 667 SITE 2 AC2 6 HOH B 683 HOH B 684 SITE 1 AC3 24 ASP A 4 SER A 6 PRO A 7 LYS A 8 SITE 2 AC3 24 ASP A 13 PHE A 14 PHE A 15 ARG A 39 SITE 3 AC3 24 THR A 40 GLY A 41 LYS A 42 SER A 43 SITE 4 AC3 24 SER A 44 PHE A 216 PRO A 242 GLY A 243 SITE 5 AC3 24 THR A 246 MG A 400 EDO A 503 HOH A 519 SITE 6 AC3 24 HOH A 616 HOH A 637 HOH A 668 HOH A 670 SITE 1 AC4 24 ASP B 4 THR B 5 SER B 6 PRO B 7 SITE 2 AC4 24 LYS B 8 PHE B 14 PHE B 15 ARG B 39 SITE 3 AC4 24 THR B 40 GLY B 41 LYS B 42 SER B 43 SITE 4 AC4 24 SER B 44 PHE B 216 PRO B 242 GLY B 243 SITE 5 AC4 24 THR B 246 MG B 400 HOH B 515 HOH B 600 SITE 6 AC4 24 HOH B 628 HOH B 666 HOH B 683 HOH B 684 SITE 1 AC5 5 PRO A 56 TYR A 57 LYS A 86 LEU A 87 SITE 2 AC5 5 HOH A 579 SITE 1 AC6 7 TYR A 183 ALA A 199 PHE A 200 HOH A 627 SITE 2 AC6 7 PHE B 250 ILE B 251 ASP B 254 SITE 1 AC7 5 ARG A 39 GLY A 243 TYR A 268 ADP A 500 SITE 2 AC7 5 HOH A 589 SITE 1 AC8 2 LYS A 47 TYR A 57 SITE 1 AC9 5 ASN A 155 ARG A 187 ASP A 190 SER A 193 SITE 2 AC9 5 PRO A 194 SITE 1 BC1 3 ARG A 296 ALA A 354 PHE A 355 SITE 1 BC2 5 LEU B 121 SER B 122 PHE B 123 ALA B 124 SITE 2 BC2 5 ALA B 159 CRYST1 55.360 108.350 70.570 90.00 100.31 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018064 0.000000 0.003286 0.00000 SCALE2 0.000000 0.009229 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014403 0.00000